These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 27620884)

  • 1. Evaluation of the effect of compression therapy using surgical gloves on nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a phase II multicenter study by the Kamigata Breast Cancer Study Group.
    Tsuyuki S; Senda N; Kanng Y; Yamaguchi A; Yoshibayashi H; Kikawa Y; Katakami N; Kato H; Hashimoto T; Okuno T; Yamauchi A; Inamoto T
    Breast Cancer Res Treat; 2016 Nov; 160(1):61-67. PubMed ID: 27620884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of surgical glove compression therapy as a prophylactic method against nanoparticle albumin-bound-paclitaxel-induced peripheral neuropathy.
    Tsuyuki S; Yamagami K; Yoshibayashi H; Sugie T; Mizuno Y; Tanaka S; Kato H; Okuno T; Ogura N; Yamashiro H; Takuwa H; Kikawa Y; Hashimoto T; Kato T; Takahara S; Katayama T; Yamauchi A; Inamoto T
    Breast; 2019 Oct; 47():22-27. PubMed ID: 31302389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial.
    Kanbayashi Y; Sakaguchi K; Ishikawa T; Ouchi Y; Nakatsukasa K; Tabuchi Y; Kanehisa F; Hiramatsu M; Takagi R; Yokota I; Katoh N; Taguchi T
    Breast; 2020 Feb; 49():219-224. PubMed ID: 31901783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compression therapy using surgical gloves does not prevent paclitaxel-induced peripheral neuropathy: results from a double-blind phase 2 trial.
    Kotani H; Terada M; Mori M; Horisawa N; Sugino K; Kataoka A; Adachi Y; Gondou N; Yoshimura A; Hattori M; Sawaki M; Takahata C; Kobara M; Iwata H
    BMC Cancer; 2021 May; 21(1):548. PubMed ID: 33985457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer.
    Takashima T; Kawajiri H; Nishimori T; Tei S; Nishimura S; Yamagata S; Tokunaga S; Mizuyama Y; Sunami T; Tezuka K; Ikeda K; Ogawa Y; Kashiwagi S; Noda S; Onoda N; Ishikawa T; Kudoh S; Takada M; Hirakawa K; Ohira M
    Anticancer Res; 2018 Jan; 38(1):379-383. PubMed ID: 29277798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of the development of nab-paclitaxel-induced peripheral neuropathy in breast cancer patients: post hoc analysis of a prospective, phase II, self-controlled clinical trial.
    Kanbayashi Y; Sakaguchi K; Ishikawa T; Tabuchi Y; Takagi R; Yokota I; Katoh N; Takayama K; Taguchi T
    Med Oncol; 2022 Jul; 39(10):153. PubMed ID: 35852641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of peripheral neuropathy induced by nab-paclitaxel treatment for breast cancer.
    Ohno T; Mine T; Yoshioka H; Kosaka M; Matsuda S; De Kerckhove M; De Kerckhove C; Irie J; Inoue K; Haraguchi M; Kitajima M; Shinichiro I; Tokai H; Tanaka T; Izumida R
    Anticancer Res; 2014 Aug; 34(8):4213-6. PubMed ID: 25075049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
    Tanaka S; Iwamoto M; Kimura K; Matsunami N; Morishima H; Yoshidome K; Nomura T; Morimoto T; Yamamoto D; Tsubota Y; Kobayashi T; Uchiyama K
    Clin Breast Cancer; 2015 Jun; 15(3):191-6. PubMed ID: 25579459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
    Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
    BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibility of Prolonging Treatment by Preventing Paclitaxel-Induced Peripheral Neuropathy Using Compression Therapy].
    Tsuyuki S; Hamada-Nishimoto M; Kang Y; Katayama T
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1241-1245. PubMed ID: 36412028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-negative Breast Cancer.
    Matsui A; Tatibana A; Suzuki N; Hirata M; Oishi Y; Hamaguchi Y; Murata Y; Nagayama A; Iwata Y; Okamoto Y
    Anticancer Res; 2017 Nov; 37(11):6481-6488. PubMed ID: 29061836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy in HER2-negative breast cancer.
    Yang M; Qu H; Liu A; Liu J; Sun P; Li H
    J Cancer Res Ther; 2019; 15(7):1561-1566. PubMed ID: 31939438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).
    Futamura M; Oba M; Masuda N; Bando H; Okada M; Yamamoto Y; Kin T; Saeki T; Nagashima T; Kuwayama T; Toh U; Hirano A; Inokuchi M; Yamagami K; Mizuno Y; Kojima Y; Nakayama T; Yasojima H; Ohno S
    Breast Cancer; 2021 Sep; 28(5):1023-1037. PubMed ID: 33811599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy without Exacerbation].
    Uchiyama M; Goto T; Ueno M; Kakimoto H; Mashima K; Ikari Y; Takamatsu Y; Ogata K; Kamimura H
    Gan To Kagaku Ryoho; 2017 Jun; 44(6):517-519. PubMed ID: 28698445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cryotherapy on paclitaxel-induced peripheral neuropathy of the hand in female breast cancer patients: A prospective self-controlled study.
    Yang TT; Pai HC; Chen CY
    Int J Nurs Pract; 2023 Aug; 29(4):e13094. PubMed ID: 35971279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Chemotherapy-Induced Peripheral Neuropathy Caused by Nanoparticle Albumin-Bound Paclitaxel in Advanced Breast Cancer.
    Guo Q; Zhang H; Li X; Quan X
    Biomed Res Int; 2022; 2022():9430952. PubMed ID: 36147633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Cystoid Macular Edema Secondary to Albumin-Bound Paclitaxel Therapy].
    Ito T; Deguchi K; Yoshii K; Kashii M
    Gan To Kagaku Ryoho; 2017 Jul; 44(7):599-602. PubMed ID: 28790265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer.
    Zhang W; Xu Y; Shi X; Huang X; Chen R; Xu H; Shi W; Wan X; Wang Y; He J; Li C; Wang J; Zha X
    Nanomedicine (Lond); 2022 Apr; 17(10):683-694. PubMed ID: 35393861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of two-weekly nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for breast cancer.
    Xie F; Chen R; Zhang L; Yin Z; Zhu Q; You S; Jiang C; Li Y; Li S; Zha X; Wang J
    Nanomedicine (Lond); 2019 Jun; 14(12):1595-1603. PubMed ID: 30977429
    [No Abstract]   [Full Text] [Related]  

  • 20. Cold therapy to prevent paclitaxel-induced peripheral neuropathy.
    Griffiths C; Kwon N; Beaumont JL; Paice JA
    Support Care Cancer; 2018 Oct; 26(10):3461-3469. PubMed ID: 29681015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.